SA
FATRX logo
Frost Total Return Bond Fund Investor Class Shares(FATRX)
Last print unknown agoAbout this dataData status
$9.17▲0.01 (0.11%)Stale · unknown old

S&P 500, Nasdaq, Russell 2000 below the 200-day average · VIX 32.1 · very high volatility

Overview →

Frost Total Return Bond Fund Investor Class Shares (FATRX)

Operating Expenses

$23.42M

TTM · Period ending: · USD

FATRX logo

FATRX Operating Expenses

Latest reported$23.42M
FATRX FY Operating Expenses ($16.13M → $23.42M)
High-resolution chart · PNG

What is operating expenses?

Expenses from normal business operations (SG&A, R&D, etc.).

FATRX operating expenses history

Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Frost Total Return Bond Fund Investor Class Shares Operating Expenses — Annual fiscal periods (USD)
Period endingOperating Expenses (USD)
23,421,797
103,751,546
107,492,647
12,479,025
74,976,683
25,685,137
15,807,852
6,815,681
9,261,005
47,475,481
1,654
16,125,065

Frequently asked questions: FATRX operating expenses

What is Frost Total Return Bond Fund Investor Class Shares (FATRX)'s current operating expenses?

Frost Total Return Bond Fund Investor Class Shares (FATRX)'s latest reported operating expenses (TTM) is $23.42M as of Dec 31, 2023. Expenses from normal business operations (SG&A, R&D, etc.).

How much historical operating expenses data is available for FATRX?

Stock Alarm Pro provides 12 dated annual fiscal periods observations for Frost Total Return Bond Fund Investor Class Shares (FATRX)'s operating expenses, allowing investors to analyze multi-year trends and cycle inflection points in Chart Studio.

How can I compare FATRX's operating expenses to peers or set an alert?

You can open FATRX's operating expenses in Stock Alarm Pro Chart Studio to overlay price and valuation multiples, or set real-time alerts on FATRX delivered by push, email, or phone call.

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.